FCM
Farallon Capital Management Portfolio holdings
AUM
$15.3B
1-Year Est. Return
51.42%
This Fund
S&P 500
1 Year Est. Return
+51.42%
AUM
$18.2B
AUM Growth
+$512M
(+2.9%)
Holding
173
Top Buys
| 1 | +$514M | |
| 2 | +$507M | |
| 3 | +$444M | |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
Boston Scientific
BSX
|
+$264M |
Top Sells
| 1 | +$528M | |
| 2 | +$352M | |
| 3 | +$333M | |
| 4 |
Intuit
INTU
|
+$333M |
| 5 |
K
Kellanova
K
|
+$323M |
Sector Composition
| 1 | Healthcare | 52.09% |
| 2 | Technology | 16.07% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 5.7% |
| 5 | Communication Services | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$32.2B
| $1.16B | 6.38% |
14,582,796
-42,896
|
|
||
2
Microsoft
MSFT
$3.11T
| $1.07B | 5.88% |
2,214,079
+300,944
|
|
||
3
Amazon
AMZN
$2.86T
| $1.04B | 5.7% |
4,499,894
+994,194
|
|
||
4
Aon
AON
$69.4B
| $941M | 5.17% |
2,665,238
+387,221
|
|
||
5
Natera
NTRA
$29.1B
| $897M | 4.92% |
3,914,366
-339,086
|
|
||
|
6
Boston Scientific
BSX
$85.9B
| $709M | 3.9% |
7,439,564
+2,693,007
|
|
||
7
Exelixis
EXEL
$12.6B
| $689M | 3.78% |
15,709,500
-3,792,000
|
|
||
8
BridgeBio Pharma
BBIO
$13.5B
| $688M | 3.78% |
8,998,463
+806,463
|
|
||
|
EXAS
9
DELISTED
Exact Sciences
EXAS
| $650M | 3.57% |
+6,405,000
|
|
||
10
Protagonist Therapeutics
PTGX
$6.38B
| $537M | 2.95% |
6,144,006
-52,000
|
|
||
11
Wabtec
WAB
$43.5B
| $529M | 2.9% |
2,476,003
+270,905
|
|
||
12
UnitedHealth
UNH
$353B
| $528M | 2.9% |
1,598,906
-287,594
|
|
||
|
CYBR
13
DELISTED
CyberArk
CYBR
| $470M | 2.58% |
+1,053,040
|
|
||
14
Walt Disney
DIS
$179B
| $469M | 2.58% |
4,125,991
-1,072,977
|
|
||
15
Synopsys
SNPS
$101B
| $469M | 2.58% |
+999,200
|
|
||
16
Thermo Fisher Scientific
TMO
$167B
| $368M | 2.02% |
635,685
-622,556
|
|
||
17
Lantheus
LNTH
$6.71B
| $361M | 1.98% |
5,427,479
+1,950,252
|
|
||
18
Aramark
ARMK
$13.5B
| $345M | 1.89% |
9,357,046
+360,844
|
|
||
19
Salesforce
CRM
$147B
| $334M | 1.83% |
1,261,177
-1,201,133
|
|
||
20
Charles Schwab
SCHW
$157B
| $334M | 1.83% |
3,339,657
+88,000
|
|
||
21
Crinetics Pharmaceuticals
CRNX
$3.88B
| $323M | 1.77% |
6,933,098
+1,163,000
|
|
||
|
22
Broadcom
AVGO
$1.96T
| $309M | 1.7% |
+892,400
|
|
||
23
Liquidia Corp
LQDA
$5.42B
| $299M | 1.64% |
8,656,038
+90,400
|
|
||
24
Nasdaq
NDAQ
$51.5B
| $290M | 1.59% |
2,989,213
-633,830
|
|
||
25
Beam Therapeutics
BEAM
$2.95B
| $279M | 1.53% |
10,063,111
|
|